Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2018-03-13
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether azacitidine is safe and effective in the
treatment of Chinese patients with higher risk Myelodysplastic Syndromes (MDS).